Roche, Mer­ck and Pfiz­er lead US phar­ma cor­po­rate rep­u­ta­tion rank­ing by pa­tient groups

While pa­tient groups in the US still view the phar­ma in­dus­try pos­i­tive­ly over­all, its rep­u­ta­tion is lev­el­ing out as af­ford­abil­i­ty con­cerns re­take cen­ter stage. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER